tiprankstipranks
Evoke Pharma (EVOK)
NASDAQ:EVOK

Evoke Pharma Financial Statements

416 Followers

Evoke Pharma Financial Overview

Evoke Pharma's market cap is currently ―. The company's EPS TTM is $-2.844; its P/E ratio is -0.70; Evoke Pharma is scheduled to report earnings on November 15, 2022, and the estimated EPS forecast is $-0.66. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement
Total Revenue$ 461.80K$ 418.38K$ 360.57K$ 930.45K$ 236.63K
Gross Profit$ 394.02K$ 395.62K$ 223.89K$ 872.01K$ 168.38K
EBIT$ -2.11M$ -2.05M$ -1.55M$ -1.84M$ -2.17M
EBITDA$ -2.11M$ -2.05M$ -1.55M$ -1.84M$ -2.17M
Net Income Common Stockholders$ -2.23M$ -2.17M$ -1.67M$ -1.97M$ -2.29M
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 6.28M$ 7.70M$ 8.07M$ 9.14M$ 11.14M
Total Assets$ 14.40M$ 9.03M$ 10.57M$ 11.65M$ 17.56M
Total Debt$ 2.01M$ 5.05M$ 84.93K$ 119.93K$ 140.28K
Net Debt$ -4.27M$ -2.65M$ -7.98M$ -9.02M$ -11.00M
Total Liabilities$ 7.21M$ 7.09M$ 7.02M$ 6.88M$ 11.59M
Stockholders Equity$ 1.93M$ 3.56M$ 4.77M$ 5.97M$ 7.19M
Cash Flow
Free Cash Flow$ -1.37M$ -1.62M$ -2.00M$ -5.89M$ -1.51M
Operating Cash Flow$ -1.37M$ -1.62M$ -2.00M$ -5.89M$ -1.51M
Investing Cash Flow$ ―$ ―$ ―$ ―$ ―
Financing Cash Flow$ 7.12M$ 171.52K$ 0.00$ 313.11K$ 45.45K
Currency in USD

Evoke Pharma Earnings and Revenue History


Evoke Pharma Debt to Assets


Evoke Pharma Cash Flow


Evoke Pharma Forecast EPS vs Actual EPS


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis